Optic Neuritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Optic Neuritis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Optic Neuritis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report also reviews key players involved in therapeutic development for Optic Neuritis (Ophthalmology) and features dormant and discontinued projects.
Optic Neuritis Pipeline Drugs Market Segmentation by Targets
The key targets of the Optic Neuritis pipeline drugs market are Deoxycytidine Kinase, Glucocorticoid Receptor, Myelin Associated Glycoprotein, Myelin Oligodendrocyte Glycoprotein, Reticulon 4, Ribonucleoside Diphosphate Reductase, and Serine/Threonine Protein Kinase Sgk2.
Optic Neuritis Pipeline Drugs Market Analysis, by Targets
For more Optic Neuritis pipeline drugs market target insights, download a free report sample
Optic Neuritis Pipeline Drugs Market Segmentation by Mechanism of Actions
The key mechanism of actions of the Optic Neuritis pipeline drugs market are Deoxycytidine Kinase Inhibitor, Glucocorticoid Receptor Agonist, Myelin Associated Glycoprotein Inhibitor, Myelin Oligodendrocyte Glycoprotein Inhibitor, Reticulon 4 Inhibitor, Ribonucleoside Diphosphate Reductase Inhibitor, and Serine/Threonine Protein Kinase Sgk2 Activator.
Optic Neuritis Pipeline Drugs Market Analysis, by Mechanism of Actions
For more mechanism of action insights into the Optic Neuritis pipeline drugs market, download a free report sample
Optic Neuritis Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Optic Neuritis pipeline drugs market are oral, intravenous, topical, buccal, intraocular, nasal, ophthalmic, subcutaneous, and sublingual.
Optic Neuritis Pipeline Drugs Market Analysis, by Routes of Administration
For more routes of administration insights into Optic Neuritis pipeline drugs market, download a free report sample
Optic Neuritis Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the Optic Neuritis pipeline drugs market are small molecule, cell therapy, fusion protein, gene therapy, peptide, protein, and subunit vaccine.
Optic Neuritis Pipeline Drugs Market Analysis, by Molecule Types
For more molecule type insights into the Optic Neuritis pipeline drugs market, download a free report sample
Competitive Landscape
Some of the leading companies in the Optic Neuritis pipeline drugs market are Cresence AS, EnhanX Biopharm Inc, Find Therapeutics Inc, Japan Innovative Therapeutics Inc, Mitochon Pharmaceuticals Inc, Noveome Biotherapeutics Inc, Oculis SA, Parvus Therapeutics Inc, ReNetX Bio, and SanBio Co Ltd.
Optic Neuritis Pipeline Drugs Market Analysis, by Companies
To know more about the companies in the Optic Neuritis pipeline drugs market, download a free report sample
Optic Neuritis Pipeline Drugs Market Report Overview
Key Targets | Deoxycytidine Kinase, Glucocorticoid Receptor, Myelin Associated Glycoprotein, Myelin Oligodendrocyte Glycoprotein, Reticulon 4, Ribonucleoside Diphosphate Reductase, and Serine/Threonine Protein Kinase Sgk2 |
Key Mechanism of Actions | Deoxycytidine Kinase Inhibitor, Glucocorticoid Receptor Agonist, Myelin Associated Glycoprotein Inhibitor, Myelin Oligodendrocyte Glycoprotein Inhibitor, Reticulon 4 Inhibitor, Ribonucleoside Diphosphate Reductase Inhibitor, and Serine/Threonine Protein Kinase Sgk2 Activator |
Key Routes of Administration | Oral, Intravenous, Topical, Buccal, Intraocular, Nasal, Ophthalmic, Subcutaneous, and Sublingual |
Key Molecule Types | Small Molecule, Cell Therapy, Fusion Protein, Gene Therapy, Peptide, Protein, and Subunit Vaccine |
Leading Companies | Cresence AS, EnhanX Biopharm Inc, Find Therapeutics Inc, Japan Innovative Therapeutics Inc, Mitochon Pharmaceuticals Inc, Noveome Biotherapeutics Inc, Oculis SA, Parvus Therapeutics Inc, ReNetX Bio, and SanBio Co Ltd |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Optic Neuritis (Ophthalmology).
- Reviews of pipeline therapeutics for Optic Neuritis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- Reviews of key companies involved in Optic Neuritis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- Evaluation of Optic Neuritis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news related to pipeline therapeutics for Optic Neuritis (Ophthalmology).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Optic Neuritis (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Optic Neuritis (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
EnhanX Biopharm Inc
Find Therapeutics Inc
Japan Innovative Therapeutics Inc
Mitochon Pharmaceuticals Inc
Noveome Biotherapeutics Inc
Oculis SA
Parvus Therapeutics Inc
ReNetX Bio
SanBio Co Ltd
Trethera Corp
Worphmed Srl
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets of the Optic Neuritis pipeline drugs market?
The key targets of the Optic Neuritis pipeline drugs market are Deoxycytidine Kinase, Glucocorticoid Receptor, Myelin Associated Glycoprotein, Myelin Oligodendrocyte Glycoprotein, Reticulon 4, Ribonucleoside Diphosphate Reductase, and Serine/Threonine Protein Kinase Sgk2.
-
What are the key mechanism of actions of the Optic Neuritis pipeline drugs market?
The key mechanism of actions of the Optic Neuritis pipeline drugs market are Deoxycytidine Kinase Inhibitor, Glucocorticoid Receptor Agonist, Myelin Associated Glycoprotein Inhibitor, Myelin Oligodendrocyte Glycoprotein Inhibitor, Reticulon 4 Inhibitor, Ribonucleoside Diphosphate Reductase Inhibitor, and Serine/Threonine Protein Kinase Sgk2 Activator.
-
What are the key routes of administration in the Optic Neuritis pipeline drugs market?
The key routes of administration in the Optic Neuritis pipeline drugs market are oral, intravenous, topical, buccal, intraocular, nasal, ophthalmic, subcutaneous, and sublingual.
-
What are the key molecule types in the Optic Neuritis pipeline drugs market?
The key molecule types in the Optic Neuritis pipeline drugs market are small molecule, cell therapy, fusion protein, gene therapy, peptide, protein, and subunit vaccine.
-
Which are the leading companies in the Optic Neuritis pipeline drugs market?
Some of the leading companies in the Optic Neuritis pipeline drugs market are Cresence AS, EnhanX Biopharm Inc, Find Therapeutics Inc, Japan Innovative Therapeutics Inc, Mitochon Pharmaceuticals Inc, Noveome Biotherapeutics Inc, Oculis SA, Parvus Therapeutics Inc, ReNetX Bio, and SanBio Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.